Long term administration of (—)-deprenyl increases mortality in male Wistar rats
Long term administration of the monoamine oxidase inhibitor (—)-deprenyl (0.5mg/Kg) for up to 20 months significantly increased mortality in the male Wistar rat, whereas the dopamine agonist pergolide (0.4mg/Kg) and the antioxidant diethyldithiocarbamate (400mg/Kg) had no significant effect on mortality. The increased mortality was not related to dietary intake or body weight of the rats. This is of interest in the light of recent evidence that (—)-deprenyl increases mortality in humans.
KeywordsLife Span Monoamine Oxidase Inhibitor Reduce Food Intake Term Administration Daily Food Intake
Unable to display preview. Download preview PDF.
- Weindruch R, Walford RL (1988) The retardation of aging and disease by dietary restriction. Charles C. Thomas, SpringfieldGoogle Scholar
- Yen TT, Knoll J (1992) Extension of life span in mice treated with Dinh lang (Policias fruticosum L) and (-)deprenyl. Acta Physiol Hungarica 79: 119–124Google Scholar